e-learning
resources
Madrid 2019
Monday, 30.09.2019
The journey towards personalized medicine in asthma: where are we now?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The pathway to inflammation in asthma: the role of the DP2 receptor
O. Palomares (Madrid, Spain)
Source:
International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Session:
The journey towards personalized medicine in asthma: where are we now?
Session type:
Evening Symposium
Number:
3466
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Palomares (Madrid, Spain). The pathway to inflammation in asthma: the role of the DP2 receptor. International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The role of purinergic P2X
7
receptors on lipopolysaccharide (LPS)-induced lung injury
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007
LATE-BREAKING ABSTRACT: A novel role for CCR3 in promoting airways hyperreactivity; Role for CCR3-muscarinic M3 receptor heterodimers
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015
Toll-like receptor stimulation induces airway hyperresponsiveness to bradykinin, an effect mediated by JNK and NF-κB signaling pathways
Source: Eur Respir J 2005; 26: Suppl. 49, 732s
Year: 2005
TGFβ overproduction in asthma reduces the epithelial repair by down-regulating the leptin/leptin receptor pathway
Source: Eur Respir J 2007; 30: Suppl. 51, 59s
Year: 2007
The muscarinic M
3
receptor regulates allergen-induced airway remodeling in mice
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
The serotoninergic receptor subtype 5-HTR1B contributes to the pathogenesis of allergic airway inflammation
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
A novel receptor antagonist, c-027, inhibits airway contraction in human and murine models of allergen, independent of inflammatory mediator release
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
The role of lipoxin A
4
and its receptor in pathogenesis of inflammatory lung diseases
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Protease-activated receptor 1 activation exaggerates allergic airway inflammation in mice
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008
Notch pathway signaling in asthma
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006
The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
The effects of formyl peptide receptor agonist on the asthma pathogenesis
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010
NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD
Source: Eur Respir J 2016; 47: 254-263
Year: 2016
Activation of eosinophils
via
toll-like receptor (TLR)3, TLR7 and TLR9: link between viral infection and asthma?
Source: Annual Congress 2007 - Novel aspects in airway inflammation in human asthma and rhinitis
Year: 2007
Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes
via
stimulation of different 5-HT receptor subtypes
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005
Inhibition of the alternative complement pathway abolishes the development of airway hyperresponsiveness (AHR) and inflammation
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004
The epidermal growth factor receptor mediates allergic airway remodelling in the rat
Source: Eur Respir J 2008; 32: 1213-1223
Year: 2008
Oral presentation: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept